Flavan-3-ols

12 studies read · 2 answers · 2 sources

Flavan-3-ols show a faint early signal for blood pressure in small human studies, while evidence for artery flexibility and healthy circulation remains insufficient.

What it does

Early findings (2)
  • Lower blood pressure · Unclear if it helps

    2 trials · 41 people · noticed in 1 weeks

  • Better blood flow · Unclear if it helps

    1 trial · 24 people

How to take it

Flavan-3-ols are worth a look if you want to support vascular function and you understand that the best human finding is improved vessel responsiveness, not a guaranteed blood pressure drop.1 The blood pressure evidence remains early and small, so do not use this as a replacement for prescribed care or monitoring. If you already manage blood pressure with a clinician, discuss any supplement change with them.2

How much

For the strongest signal so far, vessel-response studies used 400 to 900 mg daily of oral flavan-3-ols, generally for several weeks. The most favorable vessel-widening results clustered around 900 mg daily, but this is early evidence, not a proven target for everyone.1 Blood pressure studies tested roughly 400 to 993 mg daily and found only a small, inconsistent signal, so higher intake does not guarantee a meaningful change in your readings.2

When

The trials tested consistent daily intake over weeks, so this is not something researchers have established as an occasional, take-it-when-needed supplement.12 Current evidence does not identify a best time of day, a superior split-dose schedule, or a clear advantage to taking it with versus without food. Pick a routine you can repeat daily, rather than chasing a particular clock time.

Which form

Look for a product that states the actual milligrams of flavan-3-ols or cocoa flavanols, not simply the weight of cocoa powder or a proprietary blend. The human vascular research centers on quantified cocoa-derived flavan-3-ol preparations, so a label with a defined flavan-3-ol amount gives you the closest match to what trials tested.1 A dark chocolate label alone does not tell you the flavan-3-ol dose used in research.

The dose that worked, by measure (2)
Help your vessels widen with blood flow
900 mg4–12 weeks
Lower your diastolic pressure
900 mg1–12 weeks

How it works

The interesting thing about flavan-3-ols is not a quick energy boost. It is their early signal that your blood vessels respond a little better when blood needs to move.1

Flavan-3-ols are plant compounds, best known as the flavanols found in cocoa. They include compounds such as epicatechin, and research usually tests preparations that quantify their flavan-3-ol content instead of treating all chocolate products as interchangeable.1

Flavan-3-ols appear to help the cells lining your blood vessels preserve nitric oxide, a chemical message that tells the vessel wall to loosen. Think of nitric oxide as the hand signal that tells a crowded lane to open up, letting blood move through with less resistance.1 In human trials, this showed up most clearly as improved flow-mediated dilation, which measures how well an artery widens after blood flow increases.12

Studied alongside

Common questions

Do flavan-3-ols lower blood pressure?

Early results show a small blood pressure signal, but the reviewed trials do not yet establish flavan-3-ols as a reliable blood pressure tool. Effects varied across studies, and you should not use them instead of clinician-guided blood pressure care.2

What are flavan-3-ols best known for?

They are best known for supporting the way blood vessels respond when blood flow increases. Human cocoa-flavanol trials show improved flow-mediated dilation, a measure of how readily vessels widen.1

How long do flavan-3-ols take to work?

The vascular studies examined daily use over several weeks, rather than a one-time dose. The reviewed vessel-response trials ran from about 4 to 12 weeks, with a typical study lasting roughly 6 weeks.12

Sources

  1. 1. Vascular effects of cocoa rich in flavan-3-ols in humans  (2007)
  2. 2. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives  (2005)